Marco Taglietti

Affiliations

  • at Aquestive Therapeutics Inc. (AQST), 2025-06-12
  • Chief Executive Officer at Scynexis Inc (SCYX), 2022-04-28
  • Director at Delcath Systems Inc. (DCTH), 2020-05-08
  • Director at Nephrogenex Inc. (NRX), 2015-05-04
  • See Remarks at Forest Laboratories Llc (FRX), 2014-07-03
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
SCYX $3.00 75,000 $225,000.00 272,068 2022-04-26 Filing
SCYX $6.25 40,000 $250,000.00 109,668 2020-12-21 Filing
SCYX $0.90 166,667 $150,000.30 693,682 2019-12-12 Filing
SCYX $1.11 9,500 $10,545.00 526,015 2019-08-21 Filing
SCYX $1.11 500 $555.00 516,515 2019-08-20 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
FRX $35.50 3,900 $138,450.00 107,568 2012-09-06 Filing
FRX $35.51 1,200 $42,612.00 111,468 2012-09-06 Filing
FRX $35.52 7,900 $280,568.50 112,668 2012-09-06 Filing
FRX $34.72 3,000 $104,164.50 104,833 2011-05-23 Filing
FRX $32.72 600 $19,632.00 69,765 2010-11-18 Filing